March 17, 2020 / 10:37 AM / 13 days ago

BRIEF-Co-Diagnostics - FDA Policy Change To Allow Rapid Domestic Expansion Of Co-Diagnostics Covid-19 Test

March 17 (Reuters) - Co-Diagnostics Inc:

* FDA POLICY CHANGE TO ALLOW RAPID DOMESTIC EXPANSION OF CO-DIAGNOSTICS COVID-19 TEST

* CO-DIAGNOSTICS INC - NEW FDA POLICY AIMED AT EXPEDITING AVAILABILITY OF COVID-19 DIAGNOSTICS WILL ALLOW CO TO EXPAND ITS PRESENCE IN U.S. MARKET

* CO-DIAGNOSTICS INC - INTERNATIONAL SHIPMENTS OF COVID-19 TEST HAVE CONTINUED TO ESCALATE.

* CO-DIAGNOSTICS INC - “CONFIDENT IN OUR ABILITY TO MEET GROWING DEMAND FOR THIS DIAGNOSTIC” Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below